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CHAPTER I 
 
INTRODUCTION 
 
The Bcl-2 Family of Proteins 
 Apoptosis or programmed cell death is necessary to maintain homeostasis 
in the organism. Some roles for apoptosis include embryo development, tissue 
homeostasis, developing the immune repertoire and restricting the progress of 
infections.  Defective apoptosis is linked, among others, to autoimmune diseases, 
neoplastic progression and metastasis, as cells no longer respond to restraining 
signals 1. 
The Bcl-2 family is the central regulator of programmed cell death 2. Bcl-2 
was first discovered at the interchromosomal breakpoint t(14:18) in follicular B 
cell lymphomas 3, 4.  This family of proteins includes a variety of molecules with 
both anti and pro-apoptotic functions.  Members of this family all share at least 
one conserved Bcl-2 homology (BH) domain.  Three subfamilies have been 
identified. The anti-apoptosis subfamily is composed of Bcl-2, Bcl-xL, Bcl-w and 
others; the pro-apoptosis Bax subfamily is composed of Bax, Bak and Bok; and 
the pro-apoptosis BH3-only subfamily is composed of Bim, Bik, Bad, Bmf, Hrk, 
Noxa and Puma1.  
 Anti-apoptosis Bcl-2 family members guard the mitochondrial membrane 
integrity to prevent cell death 5.  For example, Bcl-2 binds the pro-apoptotic 
protein Bax at the mitochondrial membrane thus inhibiting its cell death function 6. 
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Upon cell death stimulus BH-3 only proteins can bind and activate Bax or Bak.  
They can also bind and neutralize Bcl-2 7.  Neutralization of Bcl-2 allows Bax to 
form homo-oligomers that will cause permeabilization of the outer mitochondrial 
membrane.  These events lead to the release of cytochrome C from the 
mitochondria and the activation of the caspase cascade resulting in apoptosis 1, 8, 
9.   
  
Bcl2 and Bcl-xL as Cell Cycle Regulators 
Although many studies have investigated the pro- and anti-apoptotic 
functions of the Bcl-2 family of proteins, it has been found that the anti-apoptotic 
Bcl-2 and Bcl-xL molecules also have a role in the cell cycle 10-12. It has been 
shown that cells that overexpress either Bcl-2 or Bcl-xL exhibit delayed entry into 
S-phase from quiescence 13, 14. 
Previous studies have shown that Bcl-2 mutants that failed to rescue cells 
from apoptosis also failed to delay cell cycle entry, this observation led to the 
conclusion that the anti-apoptotic and anti-proliferative functions of Bcl-2 co-
segregate 15. Moreover it was shown that cells that overexpress Bad, a pro-
apoptotic molecule that binds Bcl-xL and inhibits its anti-apoptotic function, had a 
shortened interval to S-phase from quiescence. The study suggested that the cell  
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Figure 1. Steps in the process of autophagy. Upon nutrient limitation autophagy is induced. (1) 
A double membrane bound autophagosome forms and engulfs organelles, proteins and cytosol. 
(2) The autophagosome is then trafficked to the lysosomes. (3) Fusion between the 
autophagosome and the lysosome occurs. (4) The contents of the autophagosome are degraded 
and recycled. 
 
 
cycle entry delay phenotype is dependent on the anti-apoptotic effect of Bcl-2 15.  
    Subsequent studies have indicated that the cell cycle entry delay in Bcl-
2/Bcl-xL expressing cells is due to the ability of these cells to arrest more 
efficiently in the G0 phase of the cell cycle 15. Moreover, Bcl-2/Bcl-xL cells display 
a continuous decrease in cell size and decreased protein content upon serum 
starvation or contact inhibition-induced arrest 15. Adding to the idea that an 
enhanced arrest is responsible for the cell cycle entry delay, it has been shown 
that the cyclin-dependent kinase inhibitor p27 is upregulated upon serum 
starvation-induced arrest in Bcl-2 and Bcl-xL expressing cells 13.  Bcl-2 and Bcl-
xL cell cycle entry delay phenotype is inhibited in the absence of p27. 
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Autophagy and Cell Cycle Arrest 
The characteristic cell cycle arrest phenotype observed in Bcl-2 and Bcl-
xL expressing cells resembles the autophagy-induced cell cycle arrest. 
Autophagy is the digestion of components of the cytoplasm, particularly 
membrane bound organelles, the end result being the production of amino acids 
that can then be recycled and reused by the cell.  This process is characterized 
by the formation of double membrane vesicles called autophagosomes that 
sequester cytosolic constituents and then fuse with lysosomes where enzymes 
break down the sequestered contents (Fig. 1). Autophagy occurs at basal levels 
in most tissues and plays an important role in the routine turnover of long lived 
proteins, damaged organelles and other cytoplasmic components. Autophagy 
has been implicated in diseases such as cancer, muscular disorders, 
neurodegeneration and pathogen to host response 16-21. Autophagy has even 
been implicated in the process of aging 22. Nutrient deprivation, contact inhibition 
and oxygen limiting conditions are some of the stimuli that cause the 
upregulation of this process.  Autophagy is a self-limited survival strategy and will 
eventually lead to cell death if it remains constitutively active when the absence 
of nutrients is persistent 23.   
Some studies have shown that upon cell death stimulus inhibition of 
apoptosis will result in the activation of autophagy also known as type II 
programmed cell death 24-28.  For example, Bax, Bak doubly deficient mouse 
embryonic fibroblasts (MEF), which are completely resistant to mitochondrial 
apoptosis, will undergo autophagy after death stimulation by the topoisomerase II 
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enzyme inhibitor; etoposide.  On the other hand, when Bax or Bak were 
expressed in these cells and treated with etoposide, apoptosis was induced 
instead of autophagy.  This led to the conclusion that etoposide-induced 
autophagy is activated in the absence of apoptosis, in this case in the absence of 
Bax, Bak activity 29. Bcl-2 and Bcl-xL overexpression in WT MEF inhibited 
apoptosis and also activated autophagy after etoposide treatment.  On the other 
hand WT MEF only showed a mild autophagic response and displayed apoptotic 
cell death after being exposed to etoposide. These studies suggest that 
overexpression of either Bcl-2 or Bcl-xL not only inhibits apoptosis but results in 
the enhancement of the autophagic response.    
In another study using interleukin-3-(IL-3) dependent  bax -/- bak -/- bone 
marrow cells, it was found that after growth factor withdrawal cells activated 
autophagy. An initial decline in cell size was observed as a result of cell arrest in 
the G0/G1 phase of the cell cycle.  Because during autophagy cells degrade 
intracellular substrate, the decline in cell size continued and no stable cell size 
was achieved. Furthermore, these cells displayed a decline in mitochondrial 
membrane potential and a decline in ATP.  The decline in ATP levels was not as 
great as the decline in glucose transporters, suggesting that ATP levels were 
being maintained by utilizing alternative substrates, in this case through 
autophagy 30. Inhibition of autophagy during growth factor withdrawal decreased 
 
 5
 Atg 
 mTor 
Akt/PKB 
   PTEN
Class I 
PI3K 
Beclin 1 
Class III 
PI3K 
Insulin 
receptor 
Autophagy 
3-MA 
Amino 
acids 
Rapamycin 
 
 
 
 
 
 
 
 
Figure 2.  Schematic model of autophagic regulation.  
 
cell viability suggesting that the cell survival was maintained through autophagy.  
In this study it was also found that growth factor deprivation- induced autophagy, 
impaired the ability of these cells to proliferate in response to growth factor 
stimulation. The cell must reverse the catabolic effects of autophagy. Because 
autophagy degrades organelles and proteins, including those required for cell 
cycle regulation, it took longer for these cells to re-enter S-phase 30. 
p27 is required for the cell cycle function of Bcl-xL and Bcl-2 13. Recent 
studies demonstrate that ectopic expression of p27 is sufficient to induce 
autophagy 31.  Moreover, accumulation of p27 permits the survival of cells during 
growth factor withdrawal through autophagy 31. Therefore, because Bcl-2 and 
Bcl-xL can upregulate p27 and because p27 is required for the cell cycle function 
of these proteins, it is possible that autophagy might be induced during starvation 
conditions resulting in the delayed cell cycle entry observed after release. 
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 Regulation of Autophagy 
The high capacity of autophagy to degrade entire organelles would be harmful if 
it occurred randomly.  Therefore, autophagy is tightly regulated 32. Genetic 
screening in Saccharomyces cervisiae has led to the discovery of autophagy 
(ATG) genes.  ATG genes are important in the regulation, activation and 
formation of the autophagosome.  One such gene is ATG5, which encodes a 
protein that forms an ubiquitin-like system with ATG12 33, 34.  ATG5 has been 
shown to localize to double membranes and cause the elongation of the isolation 
membrane during the formation of the autophagosome 34-36.  Mouse embryonic 
stem cells lacking ATG5 showed defects in autophagosome formation resulting 
in the inhibition of autophagy. 
Some players involved in the positive regulation of autophagy are the 
class III phosphatidylinositol 3-kinase (PI3K), Beclin 1 and UV irradiated 
resistance-associated gene (UVRAG) (Fig 2). Beclin 1 is the human homolog of 
apg6, first identified in yeast, and has also been shown to be required for 
autophagy in mammalian cells28,4737.  Together, Beclin 1, UVRAG and the class 
III PI3K form a complex that is thought to be important in mediating the 
localization of other autophagy proteins to the pre-autophagosomal structure 38.  
Inhibition of the class III PI3K by the use of methyladenine (3-MA) inhibits the 
formation of autophagosomes39.   On the other hand, the Class I PI3K and the 
mammalian target of Rapamycin (mTOR) have an inhibitory effect on autophagy 
39-41.  Upon external stimuli, such as insulin, the Class I PI3K phosphorylates the 
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lipid phosphatidylinositol at the cell membrane.  Upon phosphorylation of the lipid, 
various proteins bind it and become activated, thus transmitting the external 
signal.  Rapamycin can reverse the inhibition of autophagy caused by the Class I 
PI3K, suggesting that mTOR is a downstream target of this kinase. Moreover, 
although autophagy is sensitive to different kinds of stimuli, most of the signals 
are transduced to mTOR.  In multicellular organisms mTOR is a good regulator 
of autophagy, because it is also a sensor for amino acids and ATP 42, 43.  
We decided to investigate whether the enhanced arrest and cell cycle 
entry delay phenotype observed in Bcl-2 and Bcl-xL expressing cells is in part 
due to an enhanced autophagic response during serum starvation and contact 
inhibition induced arrest. 
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Cell Culture 
Mouse embryonic fibroblasts (MEF), M5-7 obtained from Noboru 
Mizushima (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan), bax-
/- bak-/-  mouse embryonic fibroblasts kindly provided by Craig Thompson and 
NIH 3T3 cells were cultured in Dulbecco’s modified Eagle’s Medium (DMEM) 
with 10% fetal bovine serum (FBS) or calf serum and supplemented with 2mM 
glutamine and 100 U/ml penicillin/streptomycin.  Bone marrow FL5.12 cells were 
grown in Iscove’s Modified Dulbecco’s Medium (IMDM) with 10% FBS and 
supplemented with 2mM glutamine, 100 U/ml penicillin/streptomycin and 
interleukin 3 (IL-3).   In m5-7, atg5 expression was suppressed by the addition of 
[20ng/ml] doxycycline (Calbiochem) for at least 4 days before experiments were 
carried out. Inhibition of autophagy in all other cells was performed by treating 
the cells with the indicated concentrations of 3-MA (Sigma). Bcl-2 and Bcl-xL 
constructs in pBabe or pWzL were stably introduced in NIH 3T3, FL5.12, m5-7 
and bax-/- bak-/- MEF by retroviral infection and selected with Puromycin or 
Neomycin.  Protein expression was verified by immunoblotting and 
immunofluorescence. 
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Fluorescence labeling of DNA and RNA 
Cells were collected and resuspended in ice-cold 70% ethanol.  Cells 
were then washed in PBS and resuspended in 2mg/ml pyronin Y (Polysciences, 
Inc.) and 1.25 mg/ml 7-AAD (BD PharMingen)-containing phosphate buffered 
saline (PBS) solution. Samples were analyzed by FACS.  7-AAD was measured 
in FL3 and pyronin Y staining measured in FL2.  
 
Cell cycle analysis 
 For serum starvation, cells were plated and the next day washed 3 times 
with PBS and switched to media containing 0.75 % serum.  Cells were kept in 
starvation (serum reduced) media for 3 days, collected at indicated time points 
and resuspended in Krishan’s reagent (0.02 mg/ml RNase A, 0.3% NP-40, 0.1 
mg/ml PI, and 0.1% and Na citrate).  Samples were analyzed using flow 
cytometry (FACSCalibur).  Cells were stimulated into cell cycle entry by re-
addition of 10% serum. 
 For contact inhibition, 3x106 cells were plated in 10cm plates and allowed 
to reach confluence for 3 days.  Cells were collected and processed in the same 
manner as for serum starvation. 
 For BrdU incorporation cells were treated with 20uM BrdU for 30 minutes.  
Cells were then collected and fixed in cold 70% ethanol.  After fixation, cells were 
treated with 4N HCl, neutralized with 0.1M Borax and washed in 0.05% BSA-
containing PBS.  Anti-BrdU antibody (Becton and Dickson) followed with FITC-
conjugated anti-mouse secondary antibody (Sigma) were used in 0.5% BSA and 
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0.5% Tween-20 containing PBS. Cells were then resuspended in PBS and DNA 
stained with PI in the presence of RNase A and analyzed by FACS.  
 
Cell death assay 
Cells were collected and resuspended in 100mg/ml propidium iodide (PI) 
in PBS.  The cells were then analyzed by flow cytometry.  PI positive cells were 
classified as apoptotic and PI negative cells as live cells. 
 
Western blots and antibodies 
Cell lysate electrophoresis was performed using 15% SDS-PAGE.  
Antibodies against Bcl-xL (H5) and Bcl-2 (C2) were obtained from Santa Cruz 
Biotechnology and antibodies against p27 (kip1/p27) from BD Transduction 
Laboratories.  Antibodies against LC3 were a kind gift from Noboru Mizushima. 
Equal protein loading of western blots was verified by blotting for β-actin where 
indicated. 
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CHAPTER III 
 
RESULTS 
 
Intermediate arrest phenotype in bax, bak double knockout cells  
It has been shown that Bcl-2 and Bcl-xL expressing cells display a delay 
entry into the cell cycle from arrest (Huang 1997). Delayed S-phase entry of Bcl-
xL and Bcl2 overexpressing cells is associated with prolonged arrest in G0 rather 
than in G1 (Janumyan 2003). Transition of cells from G0 to G1 is accompanied 
by an increase in polyribosomal RNA whereas the DNA content remains the 
same.  Because Bcl-2 protects the cell against cell death many have argued that 
the arrest phenotype observed is an indirect effect of this protection.  In order to 
address this question we overexpressed Bcl-2 in bax, bak double knock out (dko) 
mouse embryonic fibroblasts (MEF) (Fig. 3).  Bak and Bax are two pro-apoptotic 
proteins that are required for mitochondrial mediated programmed cell death.  If 
the anti-apoptotic function of Bcl-2 is responsible for the enhanced G0 arrest, 
then the same phenotype should be observed in bax, bak deficient cells.  Cells 
were arrested by contact inhibition and collected after 5 days of arrest and 
compared to cycling controls. We used pyronin Y (PY) which preferentially stains 
RNA and propidium iodide (PI) to stain DNA.  Cells with 2N DNA content that 
show low PY suggest an arrest in G0 rather than G1. As expected, Bcl-2 
overexpressing wt MEF had a significant decrease (~41%) in RNA content when 
arrested whereas we did not observe a significant decrease in arrested vector  
 
 
 
 
 
Figure 3. Bcl-2 overexpression in MEF. Wild type and bax-/-, bak -/- MEFs were retrovirally infected with either vector only (pBabe) or Bcl-2. (A) Bcl-2 
overexrpression as measured by immunofluorescence using flow cytometry. (B) Bcl-2 expression by Western blot. 
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Figure 4. Partial enhanced arrest in bax-/- bak-/- MEF.  Wild type and double knock out mouse embryonic fibroblasts expressing Bcl-2 or pBabe vector were arrested by 
contact inhibition and collected at day 5. (A) Cells size (Forward scatter) as measured by FACS. (B) Percentages of mean cell size from A. (C) Cells were stained for both pyronin 
Y and PI for FACS analysis. (D) Percentages of mean pyronin Y from C. These results represent two independent experiments with similar results. 
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Figure 5.  p27 upregulation in cycling Bax -/-, Bak -/- MEFs. Western blot of protein extracts 
from cyling (Cyc) and arrested cells at the indicated time points (d =days of arrest). (A) Cells were 
arrested by serum starvation (0.75% FBS containing media). (B) Cells were arrested by contact 
inhibition. 
 
 
only expressing  wt (Fig. 4C and D). On the other hand, when arrested, vector 
only bax -/- bak -/- MEF had a decrease of approximately 31% in RNA content 
suggesting that protection form apoptosis alone can result in an intermediate 
arrest phenotype between wt MEF and Bcl-2 expressing cells. No added effect 
was observed by overexpressing Bcl-2 in bax -/- bak -/- MEF.  This result 
suggests that protection from cell death by Bcl-2 overexpression is in part 
responsible for the enhanced arrest but Bax and Bak are required for the 
complete enhanced arrest phenotype to occur.  This result is in agreement with 
previous findings where the expression of pro-apoptotic Bad together with Bcl-xL 
resulted in an intermediate arrest phenotype where PY content only decreased 
partially during serum starvation 15.   
Another parameter used to identify cells in G0 is cell size, where cells 
arrested in G0 are smaller than cells in G1. As expected, arrested Bcl-2 
expressing wild type MEF decreased significantly (~37%) in cell size. On the 
other hand, cell size in vector only wild type MEF did not decreased significantly 
 15
 16
(~14%) when  arrested (Fig. 4A and B).  Again we saw that arrested bax-/- bak-/- 
MEF had an intermediate arrest phenotype and decrease more in cell size than 
arrested vector only wt.  Also, Bcl-2 overexpression in bax, bak deficient cells 
had no added effect in decreasing cell size.  The results obtained for RNA 
content and cell size suggest that inhibiting apoptosis is enough to cause an 
intermediate arrest phenotype. It has been reported that many cells will undergo 
autophagy when the apoptotic response fails subsequently leading to cell cycle 
arrest and lower RNA content.  Interestingly, we saw that in bax-/- bak -/- cells 
p27 levels were already upregulated in cycling cells (Fig 5.) when compared to 
the wild types. As mentioned earlier, studies have shown that ectopic expression 
of p27 is sufficient to induce autophagy. We decided to investigate whether 
autophagy is responsible for the enhanced cell cycle arrest phenotype observed 
in Bcl-2 and Bcl-xL overexpressing cells.  
 
3-MA has no effect on the ability of Bcl-2 to enhance arrest 
Autophagy is known to be inhibited by PI3 kinase inhibitors such as 3-
methyladenine (3-MA). We first determined the concentration of 3-MA that would 
result in less toxicity to our wt MEF (Fig. 6A and B). We exposed wt MEF to 
different concentrations of 3-MA during serum starvation conditions (0.75% FBS 
containing media) and assayed for cell death by PI exclusion/FACS. We decided 
to use 5mM 3-MA in our experiments. As expected, we saw that 3-MA had no 
toxicity in bax-/- bak-/- cells. Next we asked whether treating the Bcl-2 expressing 
cells with 3-MA during arrest would result in inhibition of enhanced arrest. We  
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Figure 6. 3-MA toxicity in MEF. The best 3-MA concentration to be used was assayed by exposing the cells to different concentrations of 3-MA and measuring 
cell death by PI exclusion at the indicated time points. Cells were exposed to 3-MA during starvation conditions (0.75% FBS- containing media). (A) Wild type 
MEFs. (B) bax -/- bak -/- MEF.  
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Figure 7.  3-MA treatment has no effect on Bcl-2 induced enhanced arrest.  Wild type MEF expressing Bcl-2 or vector only were arrested in the presence of 
5mM 3-MA and stained with both Pyronin Y and 7-AAD for FACS analysis. 100% = Mean PY fluorescence for cycling cells. (A) Cells were contact inhibited 
for 10 days.  (B) Cells were serum starved by culturing them for 3 days in 0.75% FBS-containing media (starvation media). (C) Western Blot analysis of cells 
collected at the indicated time points during starvation, where d=days of arrest and cyc=cycling cells).  Although contact inhibition was performed once, serum 
starvation results represent 3 independent experiments where no effect was seen in 3-MA treated cells. 
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treated vector only and Bcl-2 wt MEF with 5mM of 3-MA during arrest by either 
serum starvation or contact inhibition, and looked at cell size and RNA content.  
As shown, (Fig. 7A and B) there was no significant difference in RNA content 
when the cells were treated with 3-MA.  We also looked at cell size by Flow 
Cytometry, and again there was no difference between 3-MA treated cells and 
untreated control. These results were true for both contact inhibition and serum 
starvation. The same experiment was performed using Bcl-2 and vector only 
expressing bax -/- bak -/- MEF and we found that 3-MA treatment during arrest 
had no effect (data not shown). 
We also looked at p27 upregulation during arrest (Fig. 7C).  As expected 
p27 levels were upregulated during arrest and p27 was higher in our Bcl-2 
expressing cells. On the other hand we observed that there was no difference in 
3-MA treated cells and untreated controls. 
 
3-MA treatment inhibits the ability of Bcl-xL to enhance arrest in G0/G1 
Next we decided to see whether this was true in another system.  We had 
previously described Bcl-2 and Bcl-xL enhanced arrest phenotype in NIH 3T3 
cells. After looking at 3-MA toxicity in wild type 3T3 cells (Fig. 8A) we decided to 
use 5mM 3-MA during the entire period of serum starvation in our experiments.   
NIH 3T3 cells expressing either Bcl-2 or vector alone were arrested by serum 
starvation and then induced to re-enter the cell cycle by serum stimulation. S-
phase entry was measured by propidium iodide (PI) staining of the DNA content. 
As expected, vector alone control began S-phase entry at 14h after serum  
20
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 8. Bcl-2 expressing 3T3 can arrest in the presence of 3-MA during serum starvation. (A) To determine the concentration of 3-MA to be used, wild 
type 3T3 were cultured in starvation media (0.75% FBS) using different concentrations of 3-MA and cell death assayed at the indicated time points.  Cell death 
was assayed by PI exclusion and flow cytometry. (B) Bcl-2 and vector only 3T3 cells were harvested before serum starvation (10% serum) and after 3 days of  
serum starvation in 0.75% containing media in the presence of 5mM 3-MA. Cell cycle profiles were obtained by PI/FACS analysis 
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stimulation whereas Bcl-2 expressing cells were still arrested even after 20h of 
serum re-addition.  No difference between 3-MA treated and untreated Bcl-2 cells 
was observed as both groups arrested and were delayed in cell cycle entry when 
compared to vector alone (Fig. 8B).   
Because no effect was found in the timing of cell cycle entry between 3-
MA treated and untreated cells we decided to examine cells only during arrest.  
During arrest the number of cells in S and G2/M phase diminishes significantly 
and cells exit to G0/G1.  We arrested Bcl-2, Bcl-xL and vector only expressing 
cells by serum withdrawal in the presence or absence of 3-MA and measured the 
percentage of cells in S and G2/M by PI staining of DNA content. As expected, 
during arrest conditions, the number of cells in S and G2/M in untreated Bcl-2 
and Bcl-xL decreased approximately 85% (Fig. 9A and B), compared to a 60% 
decrease in the vector alone.  The decrease in S and G2/M cells in 3-MA treated 
Bcl-2 cells and vector only cells was very similar to that of untreated cells, 
although there was a greater decrease in our 3-MA treated vector alone cells.  To 
our surprise, arrested Bcl-xL expressing cells had only a 60% decrease in the 
number of cells in S and G2/M phase when treated with 3-MA.  In contrast 
untreated cells displayed a decrease of 85%. The 60% decrease in the number 
of cells in S and G2/M phase in 3-MA treated Bcl-xL cells was comparable to the 
60% decrease in the untreated vector alone cells.  This finding suggests that 3-
MA treatment during arrest inhibits the ability of Bcl-xL to enhance arrest in the 
G0/G1 phase of the cell cycle.   
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Figure 9. Bcl-xL enhanced arrest in G1/G0 is inhibited by 3-MA treatment during arrest in 3T3 cells. Bcl-xL, Bcl-2 and vector only (pBabe) expressing 
3T3 were arrested by serum starvation (0.75% FBS containing media) for 3 days in the presence of 5mM 3-MA or without 3-MA. Cells were collected before 
arrest (Cyc=cycling) and after arrest (Arr). (A) Cell cycle profiles were obtained by PI DNA staining and analyzed by flow cytometry.  (B) Shows percentage of 
cells in the S and G2/M phases from A. 100%= % of cells in S and G2/M from cycling cells. pBabe and Bcl-xL graphs represent data from 3 independent 
experiments. *Bcl-2 graph represents results from 2 independent experiments. 
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Figure 10. RNA content increase and p27 down regulation in 3-MA treated Bcl-xL cells during arrest. Bcl-xL, Bcl-2 and vector only (pBabe) expressing 
3T3 were arrested (Arr) by serum starvation (0.75% FBS containing media) for 3 days in the presence of 5mM 3-MA or without 3-MA. (A) Cells were stained 
with both Pyronin Y and 7-AAD and analyzed by flow cytometry.  Shows only arrested cells with 3-MA (Arr + 3-MA) or without 3-MA (Arr). (B) Cell size by 
forward scatter (FSC). Shows only arrested cells with or without 3-MA. 100% = Mean FSC from cycling. (C) Western blot analysis for p27. Compares cells 
before arrest (Cycling) and at day 3 of arrest with or without 3-MA. WB data represents two independent experiments. 
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We next investigated whether the effect observed in 3-MA treated Bcl-xL 
cells was due to the inability of the cells to arrest in G0.  To address this question 
we measured the RNA content by PY staining by gating on cells with 2N DNA 
content. As shown in figure 10A, arrested vector only cells treated with 3-MA 
showed no significant differences but a slight decrease in PY content when 
compared to untreated control. In contrast, a significant increase in the amount of 
PY was observed in arrested Bcl-xL cells that were treated with 3-MA when 
compared to untreated Bcl-xL controls.  Bcl-2 expressing cells displayed a slight 
increase in the amount of PY that was not as significant as the one observed in 
Bcl-xL cells.  Bcl-xL cells that arrest in the presence of 3-MA appear to be at G1 
or S-phase rather than at G0. These results are consistent with the cell cycle 
profile phenotype described earlier.  Using flow cytometry we looked at forward 
scatter (FSC) and measured cell size on arrested cells with 2N DNA content.  We 
found that there was no significant change in cell size between 3-MA treated and 
untreated cells during arrest (Fig. 10B).  We also looked at p27 expression (Fig. 
10C) upon arrest and found that in 3-MA treated Bcl-xL cells p27 appeared to 
have decreased.  
To confirm that the inhibition of enhanced G0 arrest by 3-MA in Bcl-xL 
expressing cells was consistent and not a cell line specific event we decided to 
look at the effect of autophagy inhibition in Bcl-2 and Bcl-xL overexpressing 
interleukin (IL-3)-dependent FL5.12 bone marrow cells.  We arrested these cells 
by IL-3 withdrawal and then stimulated cell cycle entry by re-addition of IL-3 into 
the media. During IL-3 withdrawal induced arrest we inhibited autophagy with 
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5mM 3-MA. Control cells began S-phase entry by 10h while Bcl-2 expressing 
cells remained arrested until 22h as expected (Fig. 11A).   Inhibition of autophagy 
during arrest in Bcl-2 cells did not have a marked effect in the cell cycle entry 
kinetics.  Both, Bcl-2 and 3-MA treated Bcl-2 cells arrested after IL-3 withdrawal 
and displayed a delayed entry into S-phase. These results are consistent with 
what we saw in Bcl-2 expressing 3T3 cells described earlier. We then looked at 
Bcl-xL overexpressing FL5.12 cells (Fig. 11B).  Again, cells were arrested by IL-3 
withdrawal and as stated earlier our control cells began cell cycle entry by 10h.  
On the other hand Bcl-xL delayed cell cycle entry until 22h after growth factor 
stimulation.  Consistent with our 3T3 results, Bcl-xL cells treated with 3-MA did 
not show enhanced arrest in G0 and the cell cycle profile showed increased 
number of cells in S-phase during arrest conditions.  This experiment was 
repeated twice with consistent results. In contrast to what we saw earlier in 3T3 
cells, arrest induced p27 upregulation  in Bcl-xL cells remained unaltered in the 
presence of 3-MA (Fig 11C). 
Because 3-MA is a PI3 kinase inhibitor it does not specifically inhibit the 
Class III PI3 kinase responsible for inducing autophagy but both the Class I and 
Class III PI3 kinases. It is also possible that 3-MA might suppress other growth 
factor signaling pathways. Because serum starvation will signal the cell to arrest, 
inhibition of the class I PI3 kinase and other growth factor pathways should not 
be a problem in our experiments.  Even so, we decided to further study 
autophagy using m5-7 cells, a cell line with tetracycline-regulated autophagy 44. 
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Figure 11.  Arrest in G1/G0 is inhibited by 3-MA in Bcl-xL expressing cells.  Bcl-xL, Bcl-2 and wild type (WT) 
FL5.12 cells were arrested by IL-3 withdrawal (30% IL-3-containing media) for 4 days with or without 5 mM 3-MA. 
Cell cycle profiles were obtained by PI /FACS analysis. Cells were collected before IL-3 withdrawal (cycling / 100% 
IL-3), during arrest (30% IL-3) and after re-addition (release) of IL-3 at the indicated time points (h = hours after IL-3 
stimulation). (A) Bcl-2 vs. wt cells. (B) Bcl-xL vs. wt cells. (C) Western blot analysis for A and B.  
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Figure 12.  Inhibition of autophagy in m5-7 cells.  Cells were arrested by either serum starvation (0.75% FBS containing media) or by contact inhibition in the presence or 
absence of Dox. Cells were collected before arrest (10%) and at the indicated days (d) during arrest. Cells were stained with both 7-AAD and Pyronin Y (PY) and analyzed by 
FACS. Cell size was assayed by measuring the forward scatter (FSC). (A) Western blot analysis of cells arrested by serum starvation (SS). (B) Cells were serum starved for 3 days. 
PY data is representative of 2 independent experiments. Cell size data is representative of 3 independent experiments. 100% = Mean PY or FSC for cycling cells. (C) Contact 
inhibition induced arrest. 100% = Mean PY or FSC for cycling cells. 
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The m5-7 cells are mouse fibroblasts in which expression of Atg5 is 
regulated by tetracycline or doxycycline (Dox). In the presence of Dox, Atg5 
expression is suppressed and Dox removal allows its expression (Fig. 12A).  
Because Atg5 is required for the elongation step during the formation of the 
autophagosome, its suppression results in the inhibition of autophagy. First we 
determined whether inhibition of autophagy during arrest had any effect on cell 
cycle arrest in these cells.  To confirm that autophagy was inhibited, we assayed 
for the microtubule-associated protein-1 light chain-3 (LC3) by Western blot. LC3 
is a cytosolic protein (LC3-I) that colocalizes to the membrane of 
autophagosomes (LC3-II) upon induction of autophagy 45. This change in 
localization is accompanied by conversion of the LC3-I to the LC3-II form 
resulting in a different molecular weight46, 47. As seen in figure 12A upon serum 
starvation LC3-I was converted to LC3-II suggesting that autophagy was being 
induced. On the other hand, in the presence of Dox, Atg5 was suppressed and 
the LC3-II band can no longer be observed suggesting that autophagy has been 
inhibited effectively. We then arrested m5-7 cells in the presence of Dox by either 
serum starvation or by contact inhibition (Fig. 12B and C), and assayed for RNA 
content and cell size.   During serum starvation and contact inhibition there was a 
decrease in both cell size and RNA content in the presence and in the absence 
of autophagy.  Inhibition of autophagy in m5-7 cells during arrest had no effect on 
their ability to arrest, consistent with results where vector only expressing cells 
were treated with 3-MA.  
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We next expressed Bcl-xL in the m5-7 cells as shown in figure 13A.  Expression 
of Bcl-xL partially protected these cells from cell death.  As shown in figure 13B, 
after complete serum withdrawal, the percent of cell death was approximately 2-
fold greater in vector only than in Bcl-xL cells expressing. Then we examined 
whether Bcl-xL overexpression resulted in the expected cell cycle entry delay 
and enhanced arrest in G0.  Vector only and Bcl-xL expressing m5-7 cells were 
arrested by either serum starvation of contact inhibition and then stimulated to re-
enter the cell cycle.  Time points were taken after release. Bcl-xL expressing 
cells entered the cell cycle after vector only (Fig. 14A and B).  Although the cell 
cycle entry delay observed was not as strong as we have seen previously in 
3T3s, it was consistent throughout our experiments. We did not see any 
difference in cell size between Bcl-xL and vector only during arrest (Fig. 14C). 
 
Figure 13. Bcl-xL overexpression in m5-7 cells.  Cells were retrovirally infected with either Bcl-
xL or vector only (pWzL). (A) Overexpression of Bcl-xL by Western blot analysis. (B) m5-7 cells 
were grown in the absence of serum and cell death assayed by PI exclusion at the indicated time 
points. 
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Figure 14.  Arrest phenotype in Bcl-xL expressing m5-7 cells.  Cells were arrested by either serum starvation (ss) or by contact inhibition (CI).  Cells were 
collected before arrest (Cycling= cyc), during arrest (d=days of arrest) and after release (R) at the indicated time points (h=hours after release).  Percentage of 
cells in S and G2/M phase were obtained from cell cycle profiles by PI/FACS.  (A) Cell cycle arrest was induced by serum starvation.  Cells were stimulated into 
the cell cycle by re-addition of serum to the media after day 4 (d4) of arrest. (B) Contact Inhibition induced arrest.  Cells were re-plated after day 8 (d8) of arrest 
to induce cell cycle entry. (C) Cell size for A and B. Cell size was assayed by measuring the forward scatter (FSC) using flow cytometry. 100% = Mean FSC for 
cycling cells.                   
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Because of the weak phenotype observed and because no difference in cell size 
was observed it may be possible that the expression of Bcl-xL in these cells is 
not sufficient. Also protection from cell death by Bcl-xL expression was not as 
efficient as observed in other cells overexpressing Bcl-xL.  We still decided to 
examine whether inhibition of autophagy by Atg5 suppression (Dox treated) in 
Bcl-xL m5-7 cells inhibited the ability of Bcl-xL to lower RNA content and cell size.   
Again we arrested the cells by either serum starvation or contact inhibition. 
Figure 15 compares arrested Bcl-xL or vector expressing cells in the presence or 
absence of Dox. In this experiment we found that inhibition of autophagy in 
serum starved Bcl-xL expressing cells resulted in higher (20% more) RNA 
content than in Bcl-xL cells where autophagy was not inhibited (Fig. 15A).  No 
difference in cell size was observed (Fig. 15A). On the other hand, when 
comparing Bcl-xL cells arrested by contact inhibition we did not observe any 
difference in RNA content nor in cell size between Dox treated and untreated 
controls (Fig 15B). In addition Dox treatment had no effect on p27 upregulation in 
Bcl-xL m5-7 cells (Fig. 15C).   
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Figure 15. Effect of autophagic inhibition during arrest in Bcl-xL m5-7. Shows only arrested cells. Cells were stained with both 7-AAD and Pyronin Y (PY) 
and analyzed by FACS. Cell size was assayed by measuring the forward scatter (FSC). 100% = Mean PY or FSC for cycling cells. (A) m5-7 cells expressing 
either Bcl-xL or vector only (pWzL) were arrested by serum starvation (0.2% FBS containing media) for 5 days. (B) Arrested by contact inhibition for 5 days. (C) 
Western blot analysis for A and B. Serum starved (ss) and contact inhibition (CI). 
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CHAPTER IV 
 
DISCUSSION 
 
Our results show that 3-MA treatment in Bcl-xL expressing cells inhibits 
the ability of Bcl-xL to enhance arrest in G0 suggesting that Bcl-xL enhanced 
arrest might be mediated in part through autophagy. We have also shown that 
upon 3-MA treatment in Bcl-xL cells there appears to be an accumulation of cells 
in the S-phase of the cell cycle. Preliminary data by BrdU incorporation (data not 
shown) suggests that 3-MA treated Bcl-xL cells are arrested in S-phase. These 
results are in agreement with a recent study that shows that cell cycle arrest in 
G1 and/or S-phase may contribute to autophagy (Liang 2007).   
On the other hand, no effect was seen in 3-MA treated Bcl-2 
overexpressing cells. In the presence of 3-MA, Bcl-2 expressing cells displayed 
enhanced arrest and cell cycle entry delay. In agreement with our results the 
Craig Thompson group found that silencing of Bcl-xL by siRNA in bak, bax 
double knock out MEF resulted in a marked suppression in the formation of 
autophagosomes after etoposide treatment 29. They observed that silencing of 
Bcl-2 did not suppress the autophagic response.  Although these results suggest 
functional differences between Bcl-xL and Bcl-2, it might be possible that Bcl-xL 
has a stronger phenotype that can be more readily observed.  For example, 
when we measured PY staining in 3-MA treated Bcl-2 cells during serum 
starvation, we found that there was an increase in RNA content although this 
increase was not as significant as in 3-MA treated Bcl-xL cells. 
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Our finding that 3-MA treatment in Bcl-2 expressing cells had no effect 
could reflect results of other studies that have shown that Bcl-2 binds beclin 1 
and inhibits autophagy 38, 48-50. This suggests that inhibition of autophagy by 3-
MA in Bcl-2 expressing cells is redundant, because Bcl-2 carries this same 
function. Still other studies suggest that Bcl-xL binds beclin1 and that it is 
possible that Bcl-xL is required for the induction of Atg5-Atg12 through regulation 
of Beclin 1 29. In this respect, it is possible that Bcl-2 and Bcl-xL perform 
opposing regulating roles in autophagy.   
Another possible explanation could be that upon induction of cell death a 
blockage in the apoptotic pathway might lead to the activation of autophagy.  
This has been shown to be true in bax -/- bak -/- MEF and IL-3 dependent bone 
marrow cells.  In the case of Bcl-2 and Bcl-xL overexpressing cells there is also 
protection against cell death and upon a death stimulus autophagy might be 
activated.  The activation of autophagy in Bcl-2 and Bcl-xL cell might not be as 
strong as in bax, bak deficient cells, because these cells still express Bax, and 
Bak and can still activate apoptosis although with greater resistance than vector 
only cells.  There also might be differences in the degree of protection between 
Bcl-2 and Bcl-xL overexpressing cells. 
As stated earlier a recent study shows that accumulation of p27 is 
sufficient to induce autophagy 31. In our experiments, p27 upregulation was not 
affected when Bcl-xL FL5.12 cells were treated with 3-MA, suggesting that p27 
upregulation might be upstream of the class III PI3 kinase/Beclin 1 complex.  On 
the other hand, 3-MA treated Bcl-xL expressing 3T3 appear to have a reduction 
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in the amount of p27.  This would indicate that p27 is downstream of the class III 
PI3 kinase/Beclin 1 complex.  Further investigation is necessary to better 
understand this mechanism. 
In conclusion, Bcl-xL may arrest in G0 in part through autophagy.  This 
does not appear to be true for Bcl-2 although this may be due to a weaker 
phenotype.  Further studies are necessary to confirm this function of Bcl-xL. 
Upon induction of autophagy LC3 localizes to the autophagosome. Taking 
advantage of fluorescent microscopy we will be transfecting Bcl-xL expressing 
cells with GFP-LC3. During normal conditions GFP-LC3 is expected to be seen 
diffused throughout the cytoplasm. In contrast, during starvation conditions a 
punctuate pattern should be observed suggesting localization of LC3 to the 
autophagosomal membrane. This system will allow us to determine whether Bcl-
xL cells have a stronger autophagic response during starvation conditions.   
Whether Bcl-xL induces autophagy through the upregulation of p27 
remains to be investigated.  It would be interesting to investigate whether the Bcl-
xL cell cycle phenotype can be reproduced in Bcl-xL expressing cells by Beclin-1 
or Atg5 upregulation in the absence of p27. 
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